Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 1
1987 25
1988 2
1989 3
1991 2
1992 2
1993 1
1995 2
1997 8
1998 14
1999 19
2000 25
2001 25
2002 29
2003 45
2004 45
2005 55
2006 69
2007 74
2008 128
2009 221
2010 222
2011 259
2012 404
2013 764
2014 1018
2015 1718
2016 2515
2017 2080
2018 2575
2019 2755
2020 3202
2021 3328
2022 3170
2023 3038
2024 2918
2025 2728
2026 826

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29,528 results

Results by year

Filters applied: . Clear all
Page 1
Pancreatic Cancer: Translating Tumor Biology into Actionability.
Balogun FO, Sherman MH, Park W, Soares KC, Reyngold M, Schoenfeld JD, Singhal A, Iacobuzio-Donahue CA, O'Reilly EM. Balogun FO, et al. Cancer Discov. 2026 Jul 1;16(7):1262-1279. doi: 10.1158/2159-8290.CD-25-2014. Cancer Discov. 2026. PMID: 42381464 Free PMC article. Review.
Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors.
Shukla N, Charalambous K, Li S, Ko KH, Casanova H, Buehler E, Cobbs C, Patel R, Brannon AR, Ewalt MD, Sulis ML, Carroll WL, Arcila ME, Mohibullah N, Berger M, Levine RL, Stein EM, Shah R, Cai SF. Shukla N, et al. Blood Cancer J. 2026 Jun 16;16(1):94. doi: 10.1038/s41408-026-01545-4. Blood Cancer J. 2026. PMID: 42303978 Free PMC article. No abstract available.
Quantitative analysis of lung microwave ablation zone volume and shape.
Salkin RS, Dev AB, Alexander ES, Moussa A, Sotirchos V, Sofocleous CT, Maroun G, Youssef EW, Ghosn M, Petre EN, Solomon SB, Keshavamurthy KN, Ziv E. Salkin RS, et al. Eur Radiol Exp. 2026 May 28;10(1):76. doi: 10.1186/s41747-026-00721-2. Eur Radiol Exp. 2026. PMID: 42207349 Free PMC article.
Breast Cancer Reirradiation Practice Patterns: An International Survey From the Reirradiation Collaborative Group (ReCOG).
Hong L, Poortmans P, Aznar M, Brooks ED, Casey D, Choi JI, Corradini S, Jagsi R, Keilty D, Koch A, Kronborg C, Kubeczko M, McClatchy D, Popovic M, Salerno KE, Shaitelman SF, Sharma M, Tsang Y, Mayo C, Gabryś D. Hong L, et al. Pract Radiat Oncol. 2026 May 27:S1879-8500(26)00116-5. doi: 10.1016/j.prro.2026.03.012. Online ahead of print. Pract Radiat Oncol. 2026. PMID: 42207068 Free article.
Early-Stage Hodgkin Lymphoma.
Patel K, Iyengar V, Moskowitz A. Patel K, et al. Cancer J. 2026 May-Jun 01;32(3):e0824. doi: 10.1097/PPO.0000000000000824. Epub 2026 May 21. Cancer J. 2026. PMID: 42166511 Review.
The impact of breast cancer polygenic risk score disclosure on decisional conflict around risk-reducing mastectomy in women with pathogenic BRCA1/2 variants.
Ongaro G, Salafia C, Sheikh R, Schofield E, Clark DF, Ebrahimzadeh J, Chittenden A, Stopfer JE, Brower J, Symecko H, Ovadia H, Husband A, Barr H, Mukherjee S, Hay JL, Stadler ZK, Offit K, Garber JE, Domchek SM, Robson ME, Hamilton JG. Ongaro G, et al. Genet Med. 2026 May 21;28(8):102609. doi: 10.1016/j.gim.2026.102609. Online ahead of print. Genet Med. 2026. PMID: 42165229 Free PMC article.
Human pancreatic progenitor organoids define genetic and epigenetic barriers to early PDAC transformation.
Zhang X, Wong W, Cho HS, Yang D, Dixon G, Luo R, Liu D, Torre D, Umeda S, González F, Askan G, Yavas A, Damodaran JR, Rickert RW, Kappagantula R, Pan FC, Aveson VG, Grimont A, Fall WB, Wang X, Pulecio J, Kaplan SJ, Pan H, Peng XL, Yeh JJ, Leach SD, Iacobuzio-Donahue CA, Chandwani R, Leslie CS, Huangfu D. Zhang X, et al. Dev Cell. 2026 Jun 10;61(6):1190-1207.e12. doi: 10.1016/j.devcel.2026.04.012. Epub 2026 May 19. Dev Cell. 2026. PMID: 42161274 Free PMC article.
Preoperative hypoalbuminemia and survival among patients selected for primary cytoreduction in advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Finch L, Dagher C, Harlev C, Finlan M, Kahn RM, Yeoshoua E, Iasonos A, Zhou Q, Broach V, Long KC, Gardner GJ, Sonoda Y, Abu-Rustum NR, Chi DS. Finch L, et al. Gynecol Oncol. 2026 Jun;209:138-145. doi: 10.1016/j.ygyno.2026.05.012. Epub 2026 May 15. Gynecol Oncol. 2026. PMID: 42139818 Free PMC article.
Local oxygen tension dictates hematopoietic cell growth and potency.
Ropa J, Gutch S, Wathen L, Kim SJ, Park J, Newton J, Whitacre G, Aljoufi A, Cooper S, Van't Hof W, Kaplan MH, Capitano ML. Ropa J, et al. Leukemia. 2026 Jul;40(7):1502-1515. doi: 10.1038/s41375-026-02971-w. Epub 2026 May 15. Leukemia. 2026. PMID: 42135527 Free article.
Dulaglutide-Associated Choroidal Lymphoid Hyperplasia.
Francis JH, Mendelsohn RB, Canestraro J, Koenig LR, Weseley PE, Abramson DH, Falchi L. Francis JH, et al. N Engl J Med. 2026 May 14;394(19):1959-1961. doi: 10.1056/NEJMc2600397. N Engl J Med. 2026. PMID: 42127399 Free PMC article. No abstract available.
Estrogen hormone therapy use in ovarian cancer patients under age 60 at diagnosis.
Lukey A, Salmanpour A, Kaur P, Berchuck A, Chase A, Dawson L, Grout B, Deurloo CM, Richardson J, Stuart G, Terry KL, Webb PM, Pike MC, Pearce CL, Hanley GE. Lukey A, et al. Gynecol Oncol. 2026 Jun;209:69-74. doi: 10.1016/j.ygyno.2026.04.018. Epub 2026 May 7. Gynecol Oncol. 2026. PMID: 42102524 Free article.
Pancreatic cancer.
Roth S, Apte M, Balachandran VP, Biffi G, Conroy T, Cukierman E, Dotan E, Esposito I, Grünwald BT, Klauß M, Klein AP, Malats N, O Reilly EM, Pishvaian MJ, Real FX, Saur D, Siveke JT, Michalski CW. Roth S, et al. Nat Rev Dis Primers. 2026 May 7;12(1):23. doi: 10.1038/s41572-026-00699-6. Nat Rev Dis Primers. 2026. PMID: 42098138 Review.
Interval Cancers after Negative Screening Contrast-enhanced Mammography.
Amir T, Lee CH, Eskreis-Winkler S, Hogan MP, Nissan N, Sevilimedu V, Mango VL, Feigin KN, Jochelson MS, Comstock CE, Sung JS. Amir T, et al. Radiol Imaging Cancer. 2026 May;8(3):e250559. doi: 10.1148/rycan.250559. Radiol Imaging Cancer. 2026. PMID: 42065648 Free PMC article.
Curvature on Graphs with Negative Edge Weights.
Grange D, Sun Y, Weistuch C, Elkin R, Phillips S, Deasy JO, Georgiou T. Grange D, et al. IEEE Trans Netw Sci Eng. 2026 Apr 9:10.1109/tnse.2026.3682565. doi: 10.1109/tnse.2026.3682565. Online ahead of print. IEEE Trans Netw Sci Eng. 2026. PMID: 42064467 Free PMC article.
Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial.
O'Shaughnessy J, Bidard FC, Neven P, Casalnuovo ML, Aftimos P, Saura C, Harbeck N, Carey LA, Curigliano G, Garcia-Saenz JA, Abad MF, Paula L, Park YH, Ozyilkan O, Munoz M, Barrett E, Cao S, Chawla A, Jhaveri KL. O'Shaughnessy J, et al. NPJ Breast Cancer. 2026 Apr 27;12(1):88. doi: 10.1038/s41523-026-00950-z. NPJ Breast Cancer. 2026. PMID: 42045295 Free PMC article.
Durvalumab Plus Chemotherapy in Patients With EGFR-Mutated Advanced NSCLC Whose Disease Progressed on First-Line Osimertinib: ORCHARD.
Cho BC, Nishio M, Ahn MJ, García-Campelo R, Ponce S, Baik C, Salgia R, Kim SW, Lee JS, Yoshida T, Yu HA, Goldberg SB, Johannes de Langen A, Le X, Piotrowska Z, Riess JW, Tanaka K, Ambrose H, Cosaert J, Fraenkel PG, Tang KH, Lehman JM, Smith P, Goldman JW. Cho BC, et al. JTO Clin Res Rep. 2026 Mar 23;7(4):100937. doi: 10.1016/j.jtocrr.2025.100937. eCollection 2026 Apr. JTO Clin Res Rep. 2026. PMID: 42039685 Free PMC article.
Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers.
Bock AM, Hao P, Xu Y, Luttwak E, Thiruvengadam SK, Sekaran K, Sano D, Vaughn J, Sharp J, Major A, Patel V, Smilnak G, Araujo N, Mynam R, Reef D, Palmeri M, Gerber D, Abhyankar A, Baek G, Falade A, Iqbal M, Hu B, Geethakumari PR, Durani U, Di M, Niu A, Cherng HJ, Rhodes JM, Grover N, Pophali P, Feldman T, Shanmugasundaram K, Svoboda J, Voorhees T, Diefenbach C, Karimi Y, Karmali R, Herrera AF, Torka P, Epperla N. Bock AM, et al. Hemasphere. 2026 Mar 31;10(4):e70346. doi: 10.1002/hem3.70346. eCollection 2026 Apr. Hemasphere. 2026. PMID: 42038745 Free PMC article. No abstract available.
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response.
Roshal M, Kong IY, Dinalankara W, Reichel JB, Teater M, Binder B, Zairis S, Brody JD, Park SI, Kovach AE, Gulati N, Oberley MJ, Lim MS, Barth MJ, Elemento O, Melnick A, Rabadan R, Chadburn A, Marchionni L, Giulino-Roth L, Cesarman E. Roshal M, et al. Blood Cancer J. 2026 Apr 22. doi: 10.1038/s41408-026-01502-1. Online ahead of print. Blood Cancer J. 2026. PMID: 42020367 Free article.
Ultrarapid BRAF mutation detection on supernatant cell-free DNA obtained by FNA: An accurate and expedient method for BRAF assessment in aggressive thyroid carcinomas.
Gutierrez Amezcua JM, Arcila ME, Ng DL, Feratovic R, Bilal KH, Cohen JM, Wei XJ, Kezlarian-Sachs B, Sigel CS, Agaram N, Nafa K, Salazar P, Lin O, Kim D. Gutierrez Amezcua JM, et al. Cancer Cytopathol. 2026 May;134(5):e70098. doi: 10.1002/cncy.70098. Cancer Cytopathol. 2026. PMID: 42018428 Free PMC article.
Staging of non-metastatic nasopharyngeal carcinoma with PET/CT.
Cao C, Treechairusame T, Wu Y, Shamseddine A, Yu Y, Riaz N, Gelblum DY, McBride SM, Kang JJ, Zakeri KJ, Tsai CJ, Wong RJ, Cracchiolo JR, Cohen MA, Ganly IA, Shah JP, Ho AL, Wong WL, Dunn LA, Michel LS, Sherman EJ, Lee NY. Cao C, et al. Eur Radiol. 2026 Aug;36(8):6389-6398. doi: 10.1007/s00330-026-12537-0. Epub 2026 Apr 20. Eur Radiol. 2026. PMID: 42009870
Utilization of invasive mediastinal nodal staging and prevalence of occult nodal disease in patients with synchronous primary lung cancers.
Zhou N, Tsui S, Toumbacaris N, Tan KS, Dycoco J, Chidi AP, Gray KD, Sihag S, Park BJ, Bott MJ, Adusumilli PS, Molena D, Rusch VW, Huang J, Bains MS, Rocco G, Isbell JM, Jones DR. Zhou N, et al. Lung Cancer. 2026 Jun;216:109420. doi: 10.1016/j.lungcan.2026.109420. Epub 2026 Apr 19. Lung Cancer. 2026. PMID: 42008943 Free PMC article.
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.
Baker C, Hill E, Kazandjian D, Papadimitriou M, Durante M, Pandey A, Ziccheddu B, Jelinek T, Coffey D, Walker B, Young R, Maclachlan K, Korde N, Parkinson N, Goldstein ZR, Runnels A, Hooper WF, Landau D, Robine N, Maura F, Landgren O, Diamond B. Baker C, et al. Hemasphere. 2026 Apr 16;10(4):e70367. doi: 10.1002/hem3.70367. eCollection 2026 Apr. Hemasphere. 2026. PMID: 42007449 Free PMC article.
Phase 2 trial of exercise and low-dose ibuprofen for cancer-related cognitive impairment in patients receiving chemotherapy.
Janelsins MC, Alieldin RA, Holler T, Sun H, Lin PJ, Shayne M, Huston A, Doyle K, Porto M, Tejani M, Thompson B, Magnuson A, Krebs M, Dunne RF, Mohile SG, Li CS, Gada U, Dhakal A, Hezel AF, Noel MS, Khorana AA, Yirinec BD, Kamath N, Dougherty DW, Ahles TA, Morrow GR, Mustian KM. Janelsins MC, et al. Cancer. 2026 Apr 15;132(8):e70323. doi: 10.1002/cncr.70323. Cancer. 2026. PMID: 42003280 Free PMC article. Clinical Trial.
Tisotumab vedotin plus carboplatin or pembrolizumab in recurrent or metastatic cervical cancer: 5-year results from the innovaTV 205/ENGOT-cx8/GOG-3024 study.
Van Nieuwenhuysen E, Vergote I, Randall LM, Tromp J, Lorusso D, O'Cearbhaill RE, Boere I, Pisano C, Sanchez LM, Banerjee S, Collins DC, Zikán M, Mathews C, Kümmel J, Melichar B, Jackson AL, Madsen K, Gennigens C, Ottevanger N, Ghamande S, Salutari V, Baurain JF, Reyners AKL, Chisamore M, Conte U, Windfeld K, Geiger M, Hansen H, Denys H, Cibula D, Oaknin A, Van Gorp T, Monk BJ; innovaTV 205/ENGOT-cx8/GOG-3024 investigators. Van Nieuwenhuysen E, et al. Gynecol Oncol. 2026 Apr;207S:3-13. doi: 10.1016/j.ygyno.2026.02.008. Gynecol Oncol. 2026. PMID: 42000372 Free article. Clinical Trial.
Hallmarks of liver cancer: Therapeutic implications.
Llovet JM, Pinyol R, Affo S, Yarchoan M, Gores GJ, Kelley RK, Lowe SW, Sia D, Villanueva A. Llovet JM, et al. Cell. 2026 Apr 16;189(8):2490-2514. doi: 10.1016/j.cell.2026.03.001. Cell. 2026. PMID: 41997132 Free PMC article. Review.
A CXCR4 targeting peptide delivered by silica nanoparticles eliminates migrating cancer stem cells in pancreatic ductal adenocarcinoma.
Tiwary K, Lahusen A, Inaas S, Beitzinger B, Schmid R, Harms M, Hauff S, Arnold F, Walter K, Alcala S, Hahn S, Heßmann E, Kleger A, Azoitei N, Seufferlein T, Sainz B Jr, Münch J, Lindén M, Hermann PC. Tiwary K, et al. Sci Rep. 2026 Apr 16;16(1):12588. doi: 10.1038/s41598-026-48584-2. Sci Rep. 2026. PMID: 41991735 Free PMC article.
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition.
Reyes J, Del Priore I, Chaikovsky AC, Pasnuri N, Elhossiny AM, Park J, Weiler P, Krause T, Moorman A, Snopkowski C, Takizawa M, Burdziak C, Ratnayeke N, Masilionis I, Ho YJ, Chaligné R, Romesser PB, Filliol A, Nawy T, Morris JP 4th, Zhao Z, Pasca Di Magliano M, Alonso-Curbelo D, Pe'er D, Lowe SW. Reyes J, et al. Cell. 2026 May 14;189(10):2875-2897.e53. doi: 10.1016/j.cell.2026.03.032. Epub 2026 Apr 15. Cell. 2026. PMID: 41990751 Free PMC article.
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosis.
Kemps PG, Picarsic JL, Héritier S, Donadieu J, Haroche J, Farnault L, Gaspari S, Evseev DA, Osipova DS, Druy AE, Minkov M, Picton S, Beilken A, Möhle R, Kuzmanović MB, Okuma HS, Chow CW, Campbell MA, Phillips GS, Zhou Y, Goyal G, Go RS, Yeo KK, Sisk BA, Weinstein JL, Campbell PK, Diamond EL, Emile JF. Kemps PG, et al. Blood Cancer J. 2026 Apr 14;16(1):60. doi: 10.1038/s41408-026-01498-8. Blood Cancer J. 2026. PMID: 41980922 Free PMC article. No abstract available.
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations.
Ellithi M, Raj S, Bromberg M, Goldstein I, Saldia A, Papadopoulos EB, Gyurkocza B, Ponce DM, Shaffer BC, Tamari R, Young JW, Politikos I, Shah GL, Alhomoud M, Raju G, Hughes CFM, Dahi PB, Scordo M, Giralt SA, Perales MA, Goldberg AD, Berman E, Wang X, Stein EM, Gonen M, Jakubowski AA, Lin RJ. Ellithi M, et al. Transplant Cell Ther. 2026 Jul;32(7):881.e1-881.e12. doi: 10.1016/j.jtct.2026.03.039. Epub 2026 Apr 12. Transplant Cell Ther. 2026. PMID: 41974306 Free PMC article.
Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort study.
Sanchez VA, Dinh PC Jr, Monahan PO, Fung C, Althouse S, Stump T, Rooker J, Dolan ME, Feldman DR, Hamilton RJ, Pierorazio PM, Martin NE, Huddart R, Kollmannsberger C, Root J, Sesso HD, Weinzierl M, Einhorn LH, Frisina RD, Travis LB. Sanchez VA, et al. EClinicalMedicine. 2026 Mar 31;94:103841. doi: 10.1016/j.eclinm.2026.103841. eCollection 2026 Apr. EClinicalMedicine. 2026. PMID: 41969333 Free PMC article.
Patient-reported outcomes and qualitative interviews in patients with estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the phase III EMBER-3 trial.
Curigliano G, O'Shaughnessy J, Bidard FC, Casalnuovo ML, Kim SB, Tokunaga E, Aftimos P, Saura C, Carey LA, Okera M, Melo E, Zagouri F, Magallanes-Maciel M, Karadurmus N, Bahadur S, Speck RM, Wang XA, Pradhan K, Macey J, Kitchen H, Fairhurst S, Miller J, Jhaveri KL, Harbeck N. Curigliano G, et al. ESMO Open. 2026 Apr;11(4):106945. doi: 10.1016/j.esmoop.2026.106945. Epub 2026 Apr 9. ESMO Open. 2026. PMID: 41962306 Free PMC article. Clinical Trial.
NCCN Guidelines® Insights: Distress Management, Version 1.2026.
Fann JR, Vanderlan J, Brewer BW, Corbett C, Keller J, Lahijani S, Niazi SK, Riba MB, Andersen B, Atreya CE, Braun I, Breitbart WS, Channa Y, Farabelli J, Fleishman S, Garcia S, Greenberg DB, Handzo RGF, Horyna A, Huang CH, Hutchinson S, Johns S, La Cava S, Leeper H, Martin S, Mukherjee D, Pailler M, Parnes F, Rao V, Rocha-Cadman X, Scher E, Schuster J, Thompson LMA, Usher A, Valentine AD, Montgomery S, Darlow S. Fann JR, et al. J Natl Compr Canc Netw. 2026 Apr;24(4):e260018. doi: 10.6004/jnccn.2026.0018. J Natl Compr Canc Netw. 2026. PMID: 41956112
Characterizing therapeutic target antigen expression in anaplastic carcinoma of the ovary.
Sullivan MW, Chui MH, Kanbergs AN, Green H, Gill K, Selenica P, Jungbluth AA, Long KC, Sonoda Y, Mueller JJ, Tarney C, Grisham RN, Makker V, Abu-Rustum NR, Weigelt B, O'Cearbhaill RE. Sullivan MW, et al. Gynecol Oncol Rep. 2026 Mar 26;64:102064. doi: 10.1016/j.gore.2026.102064. eCollection 2026 Apr. Gynecol Oncol Rep. 2026. PMID: 41953531 Free PMC article.
Efficacy of topical treatments for high-risk human papillomavirus in preventing CIN II+ lesions: a systematic review.
Pareja R, Agustí N, Vieira S, Mora-Soto N, Sanchez E, Fernandes A, Aristizábal B, Heredia F, Levin G, Varon ML, Pontremoli Salcedo M, Krause KJ, Abu-Rustum NR, Huh W, Rauh-Hain JA, Viveros-Carreño D. Pareja R, et al. Int J Gynecol Cancer. 2026 Apr;36(4):102729. doi: 10.1016/j.ijgc.2025.102729. Epub 2026 Mar 19. Int J Gynecol Cancer. 2026. PMID: 41951281
Beefing Up Awareness: Navigating Alpha-Gal Syndrome.
Davis MJ, Topol D, Davis ME. Davis MJ, et al. Clin J Oncol Nurs. 2026 Mar 24;30(2):118-124. doi: 10.1188/26.CJON.118-124. Clin J Oncol Nurs. 2026. PMID: 41949344 Free PMC article. Review.
Undetected Weight Loss Associates With Upstaging in Cancer Patients.
Gilmore LA, Dunsky EY, Miller AJ, Alvarez CM, Olaechea S, Gilmore BW, Ahn C, Iyengar P, Infante RE. Gilmore LA, et al. J Cachexia Sarcopenia Muscle. 2026 Apr;17(2):e70266. doi: 10.1002/jcsm.70266. J Cachexia Sarcopenia Muscle. 2026. PMID: 41947776 Free PMC article.
Anti-PD-1 antibody penpulimab plus chemotherapy for recurrent or metastatic nasopharyngeal carcinoma: a randomized, double-blind phase 3 study.
Huang S, Liu F, Qu S, Chen L, Zhou P, Qu S, Ai X, Chen Y, Liu M, Wang R, Chan KK, Zhang P, Hu C, Wen J, Zhang J, Lin Q, Li X, Gu K, Xiang L, Wang D, Li J, Lin D, Hu D, Ding J, Wang S, Huang X, Wang L, Jin F, Pfister DG, Mak MP, Marchi PRM, Jiang Y, Yang H, Hu X, Liu T, Wu D, Shreenivas A, Oliveira TB, Silva CEB, Alves GV, Li X, Yao Z, Lu D, Hu M, Wang ZM, Li B, Xia M, Chen X, Hu C, Xu T. Huang S, et al. Signal Transduct Target Ther. 2026 Apr 8;11(1):126. doi: 10.1038/s41392-026-02645-0. Signal Transduct Target Ther. 2026. PMID: 41946687 Free PMC article. Clinical Trial.
A Health Systems Analysis of Global Head and Neck Cancer Outcomes.
Dee EC, Go AE, Feliciano EJG, Wu JF, Willmann J, Lapen K, Treechairusame T, Patel MS, Ranganathan S, Hammond A, Wu Y, Singh A, Wong AM, Jacomina LE, Ma J, Iyengar P, Estilo CL, Kingham TP, Lee NY. Dee EC, et al. Laryngoscope. 2026 Apr 6. doi: 10.1002/lary.70534. Online ahead of print. Laryngoscope. 2026. PMID: 41943212
SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in KRAS G12C NSCLC.
Peters S, Hochmair M, Arbour KC, Rodriguez LP, Reck M, Leal T, R Lindsay C, Shun L, William WN, Spira AI, Sabari JK, Henning Grønberg B, Nishio M, Burns TF, Girard N, Capuzzo F, Merced A, Fasnacht N, Visseren-Grul C, Negrao MV. Peters S, et al. Future Oncol. 2026 Apr;22(9):1073-1082. doi: 10.1080/14796694.2026.2651961. Epub 2026 Apr 6. Future Oncol. 2026. PMID: 41940628 Free PMC article.
Body composition predicts poor outcomes and reveals immunometabolic dysfunction via single-cell profiling in anti-BCMA CAR T-treated myeloma.
Wiemers TC, Rade M, Grieb N, Ferle M, Dermendzhiev T, Fandrei D, Born P, Fischer L, Seiffert S, Grahnert A, Friedrich M, Baber R, Kreuz M, Metzeler KH, Herling M, Herling CD, Jentzsch M, Franke GN, Boldt A, Neumuth T, Shah UA, Köhl U, Reiche K, Denecke T, Platzbecker U, Vučinić V, Meyer HJ, Merz M. Wiemers TC, et al. Hemasphere. 2026 Mar 24;10(3):e70314. doi: 10.1002/hem3.70314. eCollection 2026 Mar. Hemasphere. 2026. PMID: 41939254 Free PMC article.
Insulin receptor expression and its association with hyperinsulinemia in triple negative breast cancer.
Engel AJ, Samuel K, Bass IR, Lin S, Antoniou IM, Yagnik R, Port E, Feldman SM, Friedman NB, Boolbol SK, Killelea B, Pilewskie M, Choi L, Galifi CA, Wood TL, Kase NG, LeRoith D, Bickell NA, Gallagher EJ. Engel AJ, et al. J Endocr Soc. 2026 Feb 17;10(4):bvag041. doi: 10.1210/jendso/bvag041. eCollection 2026 Apr. J Endocr Soc. 2026. PMID: 41929383 Free PMC article.
A convergent uPAR-positive tumor ecosystem creates broad vulnerability to CAR T cell therapy.
Zhang Z, Ho YJ, Fang X, Kim M, Li M, Luan W, Hinterleitner C, Haubner S, Kogel F, Pratt EC, Ozcelik E, Reyes J, Jiang Q, Yang VW, Chen YJ, Wang T, Liu H, Hu H, Zhuang X, Park J, Paffenholz SV, Chen K, Chang Q, Kulick A, Zhang J, Chan E, Rosiek E, Fan N, Williams RA, Wang AC, Freeman S, Tian S, Gunset G, Garcia Angus A, Lecomte N, Yildirim SY, Ali E, Wu M, Miranda IC, Antonescu CR, Basturk O, Tarcan Z, Rekhtman N, Wilson C, Basar M, Sauter JL, Al-Ahmadie HA, Singer S, Iacobuzio-Donahue C, Rudin C, de Stanchina E, Ganesh K, Romesser PB, Weigelt B, Huh DD, Leibold J, Feucht J, Vázquez-García I, Bott MJ, Zamarin D, Shah SP, Lewis JS, Amor C, Pe'er D, Mansilla-Soto J, Filliol A, Sadelain M, Lowe SW. Zhang Z, et al. Cell. 2026 May 14;189(10):2898-2917.e42. doi: 10.1016/j.cell.2026.03.002. Epub 2026 Mar 30. Cell. 2026. PMID: 41916312 Free article.
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma.
Dummer R, Sandhu S, Miller WH Jr, Butler MO, Taylor MH, Heinzerling L, Blank CU, Couselo EM, Burris HA 3rd, Postow MA, Chmielowski B, Middleton MR, Berking C, Hassel JC, Gesierich AH, Mauch C, Kleha JF, Polli A, Harney AS, di Pietro A, Ascierto PA. Dummer R, et al. Future Oncol. 2026 Apr;22(9):995-1013. doi: 10.1080/14796694.2026.2643481. Epub 2026 Mar 31. Future Oncol. 2026. PMID: 41914670 Free PMC article.
Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.
Wainberg ZA, Manji GA, Bahary N, Ulahannan SV, Pant S, Spigel DR, Uboha NV, Oberstein PE, Saeed A, Beagle B, Kim JY, Wang N, Weeder B, Shitole S, Mrouj K, Scott JR, Ensign LG, DiRenzo DM, Walters MJ, Wu W, Kaplan A, Cho S, Kabbarah O, O'Reilly EM. Wainberg ZA, et al. Nat Med. 2026 Apr;32(4):1267-1277. doi: 10.1038/s41591-026-04283-z. Epub 2026 Mar 30. Nat Med. 2026. PMID: 41912809 Free PMC article. Clinical Trial.
Decoding Negative Pigment Network.
Polo-Silveira L, Scope A, Feghali J, Busam K, Marghoob A. Polo-Silveira L, et al. Dermatol Pract Concept. 2026 Jan 30;16(1):7002. doi: 10.5826/dpc.1601a7002. Dermatol Pract Concept. 2026. PMID: 41912200 Free PMC article. No abstract available.
Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers.
Miao EA, Yeap B, Daher S, Lomibao M, Sun F, Keogh R, Lambden J, Reyes A, Peterson JL, Liang J, Liu A, Do A, Lee C, Hsu M, Evangelist M, Reuss J, Gadgeel SM, Lee M, Patil T, Lam V, Neal JW, Drilon A, Lin JJ. Miao EA, et al. JCO Precis Oncol. 2026 Mar;10(3):e2501148. doi: 10.1200/PO-25-01148. Epub 2026 Mar 30. JCO Precis Oncol. 2026. PMID: 41911514 Free PMC article.
A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer.
Johnson ML, Smit EF, Felip E, Ramalingam SS, Ahn MJ, Tsao A, Johnson BE, Offin M, Hussein M, Dagogo-Jack I, Goldman JW, Clarke JM, Negrao MV, Sanborn RE, Morgensztern D, Usari T, Wilner K, Alejandro L, Rifi N, Zhang X, Riely GJ. Johnson ML, et al. Future Oncol. 2026 Apr;22(8):873-885. doi: 10.1080/14796694.2026.2645982. Epub 2026 Mar 30. Future Oncol. 2026. PMID: 41910021 Free PMC article.
Recommendations for contouring of gross tumour volume for locally advanced lung cancer using magnetic resonance imaging.
Shiarli AM, Dubec MJ, Ahmed M, Asmussen JT, Bainbridge H, Belderbos JS, Brown S, Bussink J, Cobben D, Geurts BHJ, Hope A, Kavanagh J, Koh DM, Lalezari F, Louie AV, Merckel LG, Hoesein FAM, O'Connor JPB, Perez-Johnston R, Reeve TJ, Rimner A, van Rossum PSN, Schinagl DAX, Schytte T, Stevens C, Tan A, Tijssen RHN, Tunariu N, Herk MV, Verhoeff JJC, Wetscherek A, Wittenberg R, Woolf D, Faivre-Finn C, McDonald F. Shiarli AM, et al. Phys Imaging Radiat Oncol. 2026 Mar 15;38:100948. doi: 10.1016/j.phro.2026.100948. eCollection 2026 Mar. Phys Imaging Radiat Oncol. 2026. PMID: 41908729 Free PMC article.
mRNA Vaccines for Cancer Treatment.
Torphy RJ, Balachandran V, Soares KC. Torphy RJ, et al. Surg Oncol Clin N Am. 2026 Apr;35(2):299-316. doi: 10.1016/j.soc.2025.10.006. Epub 2026 Jan 14. Surg Oncol Clin N Am. 2026. PMID: 41903991 Review.
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.
Hebron KE, Odeniyide P, Wei Y, Gryder BE, Barr FG, Casey DL, Chen EY, Crompton BD, Dela Cruz FS, Durbin AD, Ford HL, Gatz SA, Hatley ME, Henssen AG, Hettmer S, Houghton PJ, Kendall GC, Khan J, Lupo PJ, Patel AG, Pomella S, Rota R, Schito M, Schoot RA, Shern JF, Stanton BZ, Stewart EA, Swindlehurst CA, Thomas CJ, Vakoc CR, Vaseva AV, Venkatramani R, Wexler LH, Yustein JT, Hammond S, Heske CM, Langenau DM, Linardic CM, Ignatius MS, Yohe ME. Hebron KE, et al. Cancers (Basel). 2026 Mar 10;18(6):888. doi: 10.3390/cancers18060888. Cancers (Basel). 2026. PMID: 41899494 Free PMC article. Review.
Clinical Utility of Copy Number Abnormality Analysis in the Evaluation of Melanocytic Lesions for Diagnosis and Prognosis: An Evidence-Based Review from the Cancer Genomics Consortium Working Group for Melanocytic Lesions.
Reyes Barron C, Geiersbach KB, Alomari AK, Deak KL, Golem S, Williams ES, Aypar U, Zou YS, Wei L, Chaubey A, Sahajpal N, Kolhe R, Love TM, Prokop L, Iqbal MA. Reyes Barron C, et al. Genes (Basel). 2026 Mar 18;17(3):331. doi: 10.3390/genes17030331. Genes (Basel). 2026. PMID: 41898865 Free PMC article. Review.
Precision Diagnosis in Cutaneous Head and Neck Squamous Cell Carcinoma.
Asarkar AA, Kattar N, Rao KN, Rinaldo A, Sreeram MP, de Bree E, Rodrigo JP, Chiesa-Estomba CM, Guntinas-Lichius O, Shaha AR, Ferlito A. Asarkar AA, et al. Biomedicines. 2026 Feb 28;14(3):556. doi: 10.3390/biomedicines14030556. Biomedicines. 2026. PMID: 41898204 Free PMC article. Review.
CD8 PET imaging with [89Zr]Zr-berdoxam-crefmirlimab in patients with solid tumors: the Phase II iCorrelate study.
Postow MA, Zang PD, Pal SK, Mauguen A, Farwell M, Gordon M, Hays D, Wong JYC, Chen D, Ulaner GA, Esposito G, McConathy J, Graham MM, Shields AF, Van den Abbeele AD, Butler MO, Thomas JS, Twardowski P, Narang J, Singh AP, Dey A, Maresca KP, Keliher E, Liu F, Potdevin G, Schmidt G, Le W, Wilson I, Mascioni A, Jia F, Korn R, Ferris MR, Schmiedehausen K, Pandit-Taskar N, Margolin KA. Postow MA, et al. J Immunother Cancer. 2026 Mar 27;14(3):e012208. doi: 10.1136/jitc-2025-012208. J Immunother Cancer. 2026. PMID: 41895717 Free PMC article. Clinical Trial.
Cancer type-specific variation in patterns of driver alterations across 50,000 tumors.
Bandlamudi C, Muldoon D, de Bruijn I, Zhang M, Gormally MV, Harrold EC, Nandakumar S, Smith SA, Jeng MY, Woods S, Arora K, Chatila WK, Nguyen B, Walch H, Woo J, Bielski CM, Fong C, Tran TN, Zhao G, Mehine M, Perry MA, Tischfield SE, Richards AL, Rajendran S, Zhang H, Kreitzer CK, Shah R, Huq R, Galle J, Alano T, Madupuri R, Kundra R, Jee J, Pichotta K, Waters M, Hickman RA, Dermawan JK, Chen JF, Safonov A, Stopsack KH, Kotecha RR, Rizvi HA, Friedman CF, Razavi P, Rosen E, Murciano-Goroff YR, Morris LGT, Fagin JA, Mellinghoff IK, Chi P, Shukla NN, Schoenfeld AJ, Riely GJ, Rudin CM, Drilon A, Lee JJ, Al-Ahmadie HA, Iyer G, Varghese AM, O'Reilly EM, Stadler ZK, Robson ME, Reznik E, Gao J, Mandelker D, Ostrovnaya I, Rana S, Jayakumaran G, Bowman A, Mohanty A, Balakrishnan AR, Syed A, Ptashkin RN, Casanova-Murphy J, Chakravarty D, Benayed R, Arcila ME, Chandarlapaty S, Yu HA, Rosen N, Donoghue MTA, Klebanoff CA, Yaeger R, Brannon AR, Zehir A, Ladanyi M, Schultz N, Solit DB, Berger MF. Bandlamudi C, et al. Cancer Cell. 2026 May 11;44(5):1045-1062.e6. doi: 10.1016/j.ccell.2026.03.003. Epub 2026 Mar 26. Cancer Cell. 2026. PMID: 41895280 Free PMC article.
Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers.
Ali A, Clasen SC, Blaes A, Casselli S, Deswal A, Demeter SH, Durm G, Fadol A, Ferrajoli A, Fradley MG, Herrmann J, Ibanez B, Koob S, Koczwara B, Leger KJ, Liu JE, López-Fernández T, Lyon AR, Ta NGC, Teerlink J, Yang EH, Dent S, Lenihan D. Ali A, et al. Cancer Med. 2026 Apr;15(4):e71682. doi: 10.1002/cam4.71682. Cancer Med. 2026. PMID: 41891318 Free PMC article. Review.
Survival after intensive therapy or clofarabine in fit older adults with acute myeloid leukemia: E2906 phase 3 trial.
Foran JM, Sun Z, Luger SM, Claxton DF, Lazarus HM, Arber DA, Rowe JM, Paietta E, Racevskis J, Garrett-Bakelman F, Zhang Y, Altman JK, Al-Kali A, Zheng H, Pratz KW, Broun ER, Powell BL, O'Dwyer KM, Godwin JE, Ofran Y, Litzow MR, Tallman MS. Foran JM, et al. Blood Neoplasia. 2026 Jan 14;3(2):100194. doi: 10.1016/j.bneo.2026.100194. eCollection 2026 May. Blood Neoplasia. 2026. PMID: 41890705 Free PMC article. Clinical Trial.
STAT4 drives optimal expansion and transcriptional repression of type I interferon pathway in inflammatory ILC2.
Pietropaolo G, Scarno G, Candelotti AM, Garzillo G, Di Censo C, Peruzzi G, Fionda C, Stabile H, Sozio F, D'Aquino C, Molfetta R, Leone F, Cinicola BL, Gori A, Ciancaglini C, Santopolo S, Quatrini L, Zicari AM, Shih HY, Mikami Y, Gismondi A, Bernardini G, Hsu KC, Santoni A, Sozzani S, Laffranchi M, Sciumè G. Pietropaolo G, et al. Cell Mol Life Sci. 2026 Mar 26;83(1):193. doi: 10.1007/s00018-026-06157-6. Cell Mol Life Sci. 2026. PMID: 41888408 Free PMC article.
Dietary patterns among individuals with plasma cell disorders- opportunities for targeted interventions.
Traore K, Castro F, Derkach A, Gorshein E, Serrano E, Taneja A, Hurtado Martínez JA, Lesokhin AM, Sahagun Sanchez Aldana AM, Flores Pérez PA, Usmani SZ, Ahlstrom JM, Block T, Hydren JR, Thomson CA, Shah UA. Traore K, et al. Blood Cancer J. 2026 Mar 27;16(1):42. doi: 10.1038/s41408-026-01468-0. Blood Cancer J. 2026. PMID: 41888093 Free PMC article. No abstract available.
Distinctive DNA sequence features define epigenetic longevity of inflammatory memory.
Cowley CJ, Sajjath SM, Soto-Ugaldi LF, Steiger M, Larsen SB, Carroll T, Barrows D, Mattei A, Gonzales KAU, Wang W, Li K, Meissner A, Kretzmer H, Pe'er D, Fuchs E. Cowley CJ, et al. Science. 2026 Mar 26;391(6792):eadz6830. doi: 10.1126/science.adz6830. Epub 2026 Mar 26. Science. 2026. PMID: 41886579 Free PMC article.
Linker Chemistry in Radiopharmaceutical Design.
Stoddard A, Furey K, Dehlavi G, Mane MM, Sebastiano J, Zeglis BM. Stoddard A, et al. Bioconjug Chem. 2026 Apr 15;37(4):630-657. doi: 10.1021/acs.bioconjchem.6c00056. Epub 2026 Mar 26. Bioconjug Chem. 2026. PMID: 41885300 Free PMC article. Review.
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.
Park W, O'Connor CA, Chou JF, Hilmi M, Tarcan Z, Schwartz C, Larsen M, Homsi R, Sivaprakasam K, Umeda S, Perry MA, Varghese AM, Yu KH, Balogun F, Zervoudakis A, Katz SS, Kim TH, Zhao K, Richards AL, Lecomte N, Martin Muldoon D, Karnoub E, Chatila W, Yang J, El-Dika I, Rao D, Joshi S, Foote MB, Sugarman R, Harding JJ, Epstein AS, Kelsen D, Chalassani S, Keane F, Schoenfeld JD, Singhal A, Diguglielmo E, Bandlamudi C, Song J, Ozkan HS, Hong J, Zhang H, Cardenas AI, Lao M, Melchor J, Shah R, Kang W, Mazzoni F, Soares K, Donoghue MT, Santos E, Rolston V, Reyngold M, Wei AC, Tipping M, Basturk O, Berger M, Kihn Do R, Schattner M, Jarnagin WR, Riaz N, Balachandran V, Pe'er D, Capanu M, Iacobuzio-Donahue C, O'Reilly EM. Park W, et al. Nat Med. 2026 May;32(5):1783-1793. doi: 10.1038/s41591-026-04299-5. Epub 2026 Mar 25. Nat Med. 2026. PMID: 41882405 Free PMC article. Clinical Trial.
Atezolizumab plus FOLFOX for Stage III Mismatch Repair-Deficient Colon Cancer.
Sinicrope FA, Ou FS, Arnold D, Peters WR, Behrens RJ, Lieu CH, Matin K, Cohen DJ, Potter SL, Nixon AB, Kottschade LA, Kathol E, Frankel WL, Shergill A, Hsu D, Reinacher-Schick A, Mehan P, Gold PJ, Khalil MF, Zemla T, Gatten C, O'Reilly EM, Meyerhardt JA. Sinicrope FA, et al. N Engl J Med. 2026 Mar 26;394(12):1155-1166. doi: 10.1056/NEJMoa2507874. N Engl J Med. 2026. PMID: 41880612 Free PMC article. Clinical Trial.
A Phase II Trial of Olaparib plus Pembrolizumab in Patients with Recurrent Copy Number-High/p53-Abnormal Endometrial Cancer.
Rubinstein MM, Ge JY, Zhou Q, Iasonos A, Weigelt B, Selenica P, Muldoon DM, Bandlamudi C, Kaczynski C, Paroder V, Higgins K, Shah P, Weissblum S, Lyn A, Liu YL, Bose S, Cohen SM, Green AK, Grisham RN, Kyi C, O'Cearbhaill RE, Tew WP, Berger MF, Aghajanian C, Makker V. Rubinstein MM, et al. Clin Cancer Res. 2026 Jun 15;32(12):2362-2371. doi: 10.1158/1078-0432.CCR-25-4467. Clin Cancer Res. 2026. PMID: 41880595 Free PMC article. Clinical Trial.
A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study.
Tsuboi M, Wakelee H, Garassino MC, Gao S, Luft A, Chen KN, Spicer JD, Zhu Y, Saji H, Okada M, Vanakesa T, Chen H, Zhao G, Ikeda N, Jones DR, Weksler B, Huang CS, Jensen E, Keller SM, Samkari A, Liberman M. Tsuboi M, et al. Eur J Cardiothorac Surg. 2026 Mar 10;68(3):ezag028. doi: 10.1093/ejcts/ezag028. Eur J Cardiothorac Surg. 2026. PMID: 41875364 Free PMC article. Clinical Trial.
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target.
Werner T, Thiery J, Budau KL, Topitsch A, Cosenza-Contreras M, Pinter N, Hause F, Rühlmann J, Gentile G, Heyer J, Kurowski K, Schüler J, Holzner PA, Werner M, Sigel C, Tang LH, Bronsert P, Schilling O. Werner T, et al. Nat Commun. 2026 Mar 23;17(1):2741. doi: 10.1038/s41467-026-70817-1. Nat Commun. 2026. PMID: 41872184 Free PMC article.
Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.
Hamby M, Egleston BL, Frosch ZAK, Steiner RE, Noy A, Carvajal V, Chong ER, Tolu SS, Jean-Louis G, Amengual JE, Patel R, Ahmed S, Sharp J, Voorhees T, Baiocchi R, Ramirez-Gamero A, Castillo JJ, Hamburger E, Dittus C, Nizamuddin IA, Mehta-Shah N, Thaw Dar NN, Sandoval-Sus J, Rojek AE, Riedell PA, Khan N, Danilov A, Solipuram V, Rubinstein PG, Ariotti A, Suneja G, Vartanov A, Milrod C, Olszewski AJ, Smilnak G, Ayers E, Desai S, Rhodes JM, Magarelli G, Feldman T, Pellon M, Aboulafia DM, Bae W, Galvez C, Bhatlapenumarthi V, Hamadani M, Barta SK. Hamby M, et al. Blood Cancer J. 2026 Mar 23;16(1):43. doi: 10.1038/s41408-026-01457-3. Blood Cancer J. 2026. PMID: 41872135 Free PMC article.
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas.
Mirza AS, Hosing C, Foss F, Kim S, Moskop A, Oloyede T, Abid MB, Afrough A, Ahmed S, Badar T, Barba P, Bhatt VR, Brown VI, Dahiya S, Deol A, Epperla N, Ganguly S, Grover NS, Hashmi H, Hashmi S, Hematti P, Hildebrandt GC, Hill JM Jr, Hossain NM, Ibrahim U, Johnson PC, Kharfan-Dabaja MA, Krem MM, Lekakis LJ, Maziarz RT, Murthy HS, Riedell PA, Salas MQ, Shouse G, Strouse C, Thakar MS, Turtle CJ, Woolfrey A, Wudhikarn K, Yared JA, Pasquini MC, Gowda L. Mirza AS, et al. Blood Neoplasia. 2025 Nov 25;3(2):100187. doi: 10.1016/j.bneo.2025.100187. eCollection 2026 May. Blood Neoplasia. 2025. PMID: 41867486 Free PMC article.
The E3-ome gene-centric compendium reveals the human E3 ligase landscape.
Chua NK, González-Robles TJ, Reddington CJ, Dudley-Fraser J, Birkinshaw RW, Han J, Solano A, Wong SW, Kochańczyk T, Peter JJ, Nakasone MA, Aust F, Munro J, Tong YH, Iskander J, Abeysekera W, Garnham A, Huckstep H, Ritchie ME, Wertz I, Hymowitz S, Kumar S, Conaway RC, Privé GG, Bullock AN, Babon JJ, Klevit RE, Lorenz S, Ciulli A, Fischer ES, Thomä NH, Nowak RP, Schulman BA, Rapé M, Rittinger K, Pagan JK, Bahlo M, Mackay JP, Mace PD, Lima CD, Hay RT, Komander D, Lechtenberg BC, Joazeiro CAP, Pagano M, Hofmann K, Feltham R. Chua NK, et al. Cell. 2026 Apr 2;189(7):2167-2188.e27. doi: 10.1016/j.cell.2026.01.029. Epub 2026 Mar 20. Cell. 2026. PMID: 41864206 Free PMC article.
Overall survival from the open-label phase II trial of palbociclib in patients with advanced well-differentiated/dedifferentiated liposarcoma.
Babatunde OO, Seier K, Schwartz G, Keohan ML, D'Angelo SP, Gounder MM, Chi P, Antonescu CR, Landa J, Qin LX, Crago AM, Singer S, Koff A, Tap WD, Dickson MA. Babatunde OO, et al. ESMO Open. 2026 Apr;11(4):106899. doi: 10.1016/j.esmoop.2026.106899. Epub 2026 Mar 20. ESMO Open. 2026. PMID: 41864163 Free PMC article. Clinical Trial.
Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.
Varga C, Robinson M, Davis JA, Hashmi H, Martin TG, Kumar A, Sborov DW, Wagner CB, Hansen DK, Castaneda Puglianini O, Shune L, Bhurtel E, Afrough A, Anderson LD Jr, Dhakal B, Herr MM, Richard S, Lieberman-Cribbin A, Sherbenou D, Forsberg PA, Purvey S, Khouri J, Lin Y, Sidana S, Patel KK, Kocoglu M, Midha S, Ferreri CJ. Varga C, et al. Blood Cancer J. 2026 Mar 20;16(1):39. doi: 10.1038/s41408-026-01469-z. Blood Cancer J. 2026. PMID: 41862439 Free PMC article.
Comparative effectiveness of HMA with venetoclax vs intensive chemotherapy in AML with very high-risk cytogenetics.
Aguirre LE, Bewersdorf JP, Liu Y, Shallis RM, Boussi L, Zucenka A, Garciaz S, Bystrom RP, DeAngelo DJ, Stone RM, Luskin MR, Garcia JS, Winer ES, Ling K, Chen EC, Wadleigh M, Berton G, Stein EM, Goldberg AD, Mendez L, Zeidan AM, Sallman DA, Shimony S, Stahl M. Aguirre LE, et al. Blood Neoplasia. 2026 Jan 28;3(2):100201. doi: 10.1016/j.bneo.2026.100201. eCollection 2026 May. Blood Neoplasia. 2026. PMID: 41859348 Free PMC article.
Deficiencies in the Fanconi anemia or homologous recombination pathway enhance the antitumor effects of the hypoxia-activated prodrug CP-506.
Schuitmaker L, van der Wiel AMA, Lieuwes NG, Biemans R, Mutsters NAM, Jung J, Bastos VC, Sagarra ÈP, Kuang S, Setton J, Langie SAS, Kampen KR, Theys J, Yaromina A, Dubois LJ, Lambin P. Schuitmaker L, et al. Mol Ther Oncol. 2026 Feb 24;34(1):201161. doi: 10.1016/j.omton.2026.201161. eCollection 2026 Mar 19. Mol Ther Oncol. 2026. PMID: 41859007 Free PMC article.
Tolerance and Resistance to Targeted Therapy in NSCLC: Emerging Concepts and Strategies.
Sanchez-Cespedes M, Lockwood WW, Suda K, Gardner EE, Mitsudomi T, Politi K, Rolfo C, Sen T, Sos ML, Tammela T, Wynes MW, Tsao MS, Berger AH. Sanchez-Cespedes M, et al. JTO Clin Res Rep. 2025 Dec 11;7(4):100944. doi: 10.1016/j.jtocrr.2025.100944. eCollection 2026 Apr. JTO Clin Res Rep. 2025. PMID: 41858873 Free PMC article. Review.
Development of a Novel Psychosocial Intervention to Improve Symptom Management for Adolescents and Young Adults with Advanced or Recurrent Cancer.
Dorfman CS, Somers TJ, Arrato NA, Winger JG, Herold B, Plumb Vilardaga J, Chou NA, Diachina A, Corbett CM, Wagner L, Maslow G, Breitbart WS. Dorfman CS, et al. J Adolesc Young Adult Oncol. 2026 Mar 20:21565333261425871. doi: 10.1177/21565333261425871. Online ahead of print. J Adolesc Young Adult Oncol. 2026. PMID: 41858243 Free PMC article.
Functional chromatin signatures premark future lineage-specific enhancers.
Pulecio J, Tayyebi Z, Liu D, Wong W, Luo R, Damodaran JR, Kaplan SJ, Hu N, Cho HS, Yan J, Murphy D, Rickert RW, Shukla A, Zhong A, Torre D, Li Q, González F, Yang D, Li W, Zhou T, Apostolou E, Leslie CS, Huangfu D. Pulecio J, et al. Cell Genom. 2026 May 13;6(5):101189. doi: 10.1016/j.xgen.2026.101189. Epub 2026 Mar 18. Cell Genom. 2026. PMID: 41856116 Free PMC article.
Towards Clinical Translation of Intravoxel Incoherent Motion MRI: Acquisition and Analysis Consensus Recommendations.
Sigmund EE, Rauh SS, Iima M, Federau C, Hernando D, Jalnefjord O, Jansen JFA, Jasse J, Jerome NP, Kaandorp MPT, Kurugol S, Laun FB, Liu MM, Ljimani A, Niendorf T, Reiter DA, Shazeeb MS, Shukla-Dave A, Stabinska J, Wetscherek A, While PT, Wu D, Le Bihan D, Gurney-Champion OJ. Sigmund EE, et al. J Magn Reson Imaging. 2026 Jun;63(6):1782-1801. doi: 10.1002/jmri.70278. Epub 2026 Mar 19. J Magn Reson Imaging. 2026. PMID: 41853873 Free PMC article. Review.
Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.
Hamulyák EN, Wang TF, Kreuziger LB, Iyengar V, Carney BJ, Hoeben A, Özdemir BC, Cordova Serrano RD, Sanfilippo KM, Rozenblatt S, Beenen LFM, Yust-Katz S, Halperin E, Arad A, Lubetsky A, Carrier M, Massat B, Büller HR, Spectre G, Zwicker JI, Leader A; ABC Study Group. Hamulyák EN, et al. Blood Vessel Thromb Hemost. 2026 Jan 20;3(2):100140. doi: 10.1016/j.bvth.2026.100140. eCollection 2026 May. Blood Vessel Thromb Hemost. 2026. PMID: 41852714 Free PMC article.
Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301.
Abou-Alfa GK, Borbath I, Roychowdhury S, Goyal L, Lamarca A, Macarulla T, Shroff RT, Oh DY, Tamaş C, Savastano DM, van Veenhuyzen DF, Xu C, Freas E, Solanas J, Javle MM. Abou-Alfa GK, et al. ESMO Open. 2026 Apr;11(4):106306. doi: 10.1016/j.esmoop.2026.106306. Epub 2026 Mar 17. ESMO Open. 2026. PMID: 41850040 Free PMC article. Clinical Trial.
Mastectomy for Breast Cancer in Nigeria: A Mixed-Methods Study of Barriers, Facilitators, and Patient Attitudes.
Romanoff A, Olasehinde O, Lynch K, Agodirin O, Okereke CE, Olaniyan AT, Adeleye AO, Kalvin HL, Iasonos A, Owoade IA, Kahn R, Amburn T, Fitzgerald G, Fodero R, Akinmaye RP, Awe M, Lawal S, Adeleye O, Wuraola F, Aderounmu A, Adisa A, Rosa WE, Anderson BO, Mango VL, Kingham TP, Alatise OI. Romanoff A, et al. Psychooncology. 2026 Mar;35(3):e70413. doi: 10.1002/pon.70413. Psychooncology. 2026. PMID: 41846392
Image registration improves inter-reader agreement of objective response in CT assessment of pancreas adenocarcinoma.
Heiselman JS, Horvat N, El Homsi M, Agridag-Ucpinar B, Yildirim O, Gonen M, Ecker BL, O'Reilly EM, Drebin JA, Balachandran VP, Kingham TP, Soares KC, D'Angelica MI, Do RKG, Jarnagin WR, Wei AC, Chakraborty J. Heiselman JS, et al. Eur J Radiol. 2026 Jun;199:112776. doi: 10.1016/j.ejrad.2026.112776. Epub 2026 Mar 7. Eur J Radiol. 2026. PMID: 41846066 Free PMC article.
CCAAT-enhancer binding protein delta functions as a tumor suppressor gene in acute myeloid leukemia.
Prajapati SC, Meydan C, Neelamraju Y, Wang Z, Atwood G, Paudel BB, Fan H, Dunham N, Dillon R, Gandara JA, Lee T, Sheridan C, Wang S, Zumbo P, Becker MW, Bullinger L, Carroll MP, D'Andrea RJ, Levine RL, Mason CE, Melnick AM, Zang C, Bekiranov S, Garrett-Bakelman FE. Prajapati SC, et al. Neoplasia. 2026 Apr;74:101293. doi: 10.1016/j.neo.2026.101293. Epub 2026 Mar 16. Neoplasia. 2026. PMID: 41844049 Free PMC article.
Prevalence of High-Risk Human Papillomavirus and Associated Risk Factors Among Individuals With Head and Neck Cancer in a National Referral Center in Tanzania.
Nkya A, Xu MJ, Philipo GS, Haddadi S, Ng D, Mushi BP, Malango AE, Magorosa EP, Paciorek A, Zhang L, Muya S, Ha P, Liyombo E, Richard E, Massawe W, Palefsky JM, Yom SS, Mmbaga EJ, Van Loon K. Nkya A, et al. JCO Glob Oncol. 2026 Mar;12(3):e2500596. doi: 10.1200/GO-25-00596. Epub 2026 Mar 17. JCO Glob Oncol. 2026. PMID: 41843836 Free PMC article.
Microglial fructose metabolism is essential for glioblastoma growth.
Billingham LK, DeLay SL, Eshac Y, Chia TY, Tripathi S, Olson IE, Zilinger K, Subbiah J, Wang Z, Sadagopan NS, Najem H, Cognet G, Katz JL, Du R, Nandoliya KR, Boland LK, Ignacio Vázquez-Cervantes G, Wang S, Wan H, Lipshutz AB, Murphy AR, Duffy J, Balyasnikova IV, Zhang P, Heiland DH, Ahmed AU, Lee-Chang C, Heimberger AB, Perry JSA, Muir A, Chandel NS, Miska J. Billingham LK, et al. Proc Natl Acad Sci U S A. 2026 Mar 24;123(12):e2521256123. doi: 10.1073/pnas.2521256123. Epub 2026 Mar 17. Proc Natl Acad Sci U S A. 2026. PMID: 41843684
Three-dimensional high-content imaging of unstained soft tissue with subcellular resolution using a laboratory-based X-ray microscope.
Esposito M, Astolfo A, Zhou Y, Buchanan I, Teplov A, Hutchinson JC, Endrizzi M, Vinogradova AE, Makarova O, Divan R, Tang CM, Yagi Y, Lee PD, Walsh CL, Ferrara JD, Olivo A. Esposito M, et al. Proc Natl Acad Sci U S A. 2026 Mar 24;123(12):e2525239123. doi: 10.1073/pnas.2525239123. Epub 2026 Mar 17. Proc Natl Acad Sci U S A. 2026. PMID: 41843669 Free PMC article.
Industrial Adoption of Carbon Nanotubes.
Goerzen D, Pasquali M, Kim M, Heller DA. Goerzen D, et al. Nano Lett. 2026 Apr 1;26(12):4004-4013. doi: 10.1021/acs.nanolett.5c05572. Epub 2026 Mar 17. Nano Lett. 2026. PMID: 41841531 Free PMC article. Review.
Mycobacterium tuberculosis as a model system.
Barnard E, Elgrail MM, Fay A, Ozakman Y, Glickman MS. Barnard E, et al. J Bacteriol. 2026 Apr 23;208(4):e0060925. doi: 10.1128/jb.00609-25. Epub 2026 Mar 16. J Bacteriol. 2026. PMID: 41837629 Free PMC article. Review.
Breast-implant associated unicentric castleman disease: a case report.
Shyamsundar S, Bustamante MS, Borys L, Lim MS, Bagg A, Lechowicz MJ, Alapat D, Chadburn A, Srkalovic G, van Rhee F, Austin B, Brandstadter JD, Fajgenbaum DC. Shyamsundar S, et al. Curr Probl Cancer Case Rep. 2026 Mar;21:100404. doi: 10.1016/j.cpccr.2026.100404. Epub 2026 Jan 6. Curr Probl Cancer Case Rep. 2026. PMID: 41836733 Free PMC article.
The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Impact of Common Molecular Alterations and Programmed Death-Ligand 1 Expression on Overall Survival in a Select Cohort From the International Association for the Study of Lung Cancer Ninth Edition Staging Database.
Yang SR, Tjota MY, Goren E, Giroux DJ, Galateau-Salle F, Husain AN, Kindler HL, Drazer MW, Aly R, Dycoco J, Mitchell O, Lechtenberg K, Travis WD, Rusch VW, Tsao MS, Sauter JL. Yang SR, et al. J Thorac Oncol. 2026 Jul;21(7):103681. doi: 10.1016/j.jtho.2026.103681. Epub 2026 Mar 13. J Thorac Oncol. 2026. PMID: 41833817
Opportunities for Home Cancer Care: The Final Frontier.
Doshi SD, Malling CD, Landrum KM, Zachariah F, Bange EM, Daly B. Doshi SD, et al. NEJM Catal Innov Care Deliv. 2025 Jun;6(6):10.1056/CAT.24.0451. doi: 10.1056/CAT.24.0451. Epub 2025 May 21. NEJM Catal Innov Care Deliv. 2025. PMID: 41821867 Free PMC article.
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy.
Gracilla DE, Menon S, Breese MR, Lin YP, Dela Cruz FS, Feinberg TY, de Stanchina E, Galic AF, Allegakoen H, Perati SR, Everin N, Vizconde T, Wen NJ, Heslin A, Somwar R, Ladanyi M, Horlbeck M, Weissman JS, Sweet-Cordero EA, Bivona TG, Tulpule A. Gracilla DE, et al. Cancer Res. 2026 Jun 1;86(11):2660-2677. doi: 10.1158/0008-5472.CAN-25-2166. Cancer Res. 2026. PMID: 41811428 Free PMC article.
The critical role of standards for AI in digital pathology: Digital Pathology Association Concept Paper.
Chauhan C, Parwani A, Schumacher V, Sebastian M, Bui MM, Lin PC, Blakely S, Fathima S, Gibbs J, Horchner U, Lujan G, Osamura RY, Pantanowitz L, Samboy J, Zioga C, Herrmann M, Yeh J, Oen H, Dash RC, Lennerz JK, Schmid J. Chauhan C, et al. J Pathol Inform. 2026 Feb 3;21:100645. doi: 10.1016/j.jpi.2026.100645. eCollection 2026 Apr. J Pathol Inform. 2026. PMID: 41809691 Free PMC article.
29,528 results
You have reached the last available page of results. Please see the User Guide for more information.